240 related articles for article (PubMed ID: 36620593)
1. Application of machine learning in the prediction of deficient mismatch repair in patients with colorectal cancer based on routine preoperative characterization.
Xu D; Chen R; Jiang Y; Wang S; Liu Z; Chen X; Fan X; Zhu J; Li J
Front Oncol; 2022; 12():1049305. PubMed ID: 36620593
[TBL] [Abstract][Full Text] [Related]
2. Development and external validation of a novel nomogram for screening Chinese Lynch syndrome: based on a multicenter, population study.
Yang M; Li D; Jiang W; Zhu L; Ju H; Sun Y; Shan Y; Yang C; Dong J; Wang L; Wu B; Qiu M; Yin X; Wang X; Xiong B; Yan W; Liu T; Liu C; Mao X; Ding K; Zhang S; Zheng S; Xu D; Ding P; Yuan Y
Ther Adv Med Oncol; 2021; 13():17588359211023290. PubMed ID: 34178123
[TBL] [Abstract][Full Text] [Related]
3. Performance of Next-Generation Sequencing for the Detection of Microsatellite Instability in Colorectal Cancer With Deficient DNA Mismatch Repair.
Ratovomanana T; Cohen R; Svrcek M; Renaud F; Cervera P; Siret A; Letourneur Q; Buhard O; Bourgoin P; Guillerm E; Dorard C; Nicolle R; Ayadi M; Touat M; Bielle F; Sanson M; Le Rouzic P; Buisine MP; Piessen G; Collura A; Fléjou JF; de Reyniès A; Coulet F; Ghiringhelli F; André T; Jonchère V; Duval A
Gastroenterology; 2021 Sep; 161(3):814-826.e7. PubMed ID: 33992635
[TBL] [Abstract][Full Text] [Related]
4. A noninvasive nomogram model based on CT features to predict DNA mismatch repair deficiency in gastric cancer.
Chen JY; Tong YH; Chen HY; Yang YB; Deng XY; Shao GL
Front Oncol; 2023; 13():1066352. PubMed ID: 36969034
[TBL] [Abstract][Full Text] [Related]
5. Preoperative contrast-enhanced CT imaging and clinicopathological characteristics analysis of mismatch repair-deficient colorectal cancer.
Chen S; Du W; Cao Y; Kong J; Wang X; Wang Y; Lu Y; Li X
Cancer Imaging; 2023 Oct; 23(1):97. PubMed ID: 37828626
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of yield and experiences of age-related molecular investigation for heritable and nonheritable causes of mismatch repair deficient colorectal cancer to identify Lynch syndrome.
Vos JR; Fakkert IE; Spruijt L; Willems RW; Langenveld S; Mensenkamp AR; Leter EM; Nagtegaal ID; Ligtenberg MJL; Hoogerbrugge N;
Int J Cancer; 2020 Oct; 147(8):2150-2158. PubMed ID: 32510614
[TBL] [Abstract][Full Text] [Related]
7. Artificial Intelligence for Histology-Based Detection of Microsatellite Instability and Prediction of Response to Immunotherapy in Colorectal Cancer.
Hildebrand LA; Pierce CJ; Dennis M; Paracha M; Maoz A
Cancers (Basel); 2021 Jan; 13(3):. PubMed ID: 33494280
[TBL] [Abstract][Full Text] [Related]
8. CT-based deep learning model for the prediction of DNA mismatch repair deficient colorectal cancer: a diagnostic study.
Cao W; Hu H; Guo J; Qin Q; Lian Y; Li J; Wu Q; Chen J; Wang X; Deng Y
J Transl Med; 2023 Mar; 21(1):214. PubMed ID: 36949511
[TBL] [Abstract][Full Text] [Related]
9. A Model for Predicting DNA Mismatch Repair-deficient Colorectal Cancer.
Chikatani K; Chika N; Suzuki O; Sakimoto T; Ishibashi K; Eguchi H; Okazaki Y; Ishida H
Anticancer Res; 2020 Aug; 40(8):4379-4385. PubMed ID: 32727766
[TBL] [Abstract][Full Text] [Related]
10. Development and validation of an ensemble machine-learning model for predicting early mortality among patients with bone metastases of hepatocellular carcinoma.
Long Z; Yi M; Qin Y; Ye Q; Che X; Wang S; Lei M
Front Oncol; 2023; 13():1144039. PubMed ID: 36890826
[TBL] [Abstract][Full Text] [Related]
11. Development and Interpretation of a Clinicopathological-Based Model for the Identification of Microsatellite Instability in Colorectal Cancer.
Jiang Z; Yan L; Deng S; Gu J; Qin L; Mao F; Xue Y; Cai W; Nie X; Liu H; Shang F; Tao K; Wang J; Wu K; Cao Y; Cai K
Dis Markers; 2023; 2023():5178750. PubMed ID: 36860582
[TBL] [Abstract][Full Text] [Related]
12. Detecting immunotherapy-sensitive subtype in gastric cancer using histologic image-based deep learning.
Hinata M; Ushiku T
Sci Rep; 2021 Nov; 11(1):22636. PubMed ID: 34811485
[TBL] [Abstract][Full Text] [Related]
13. Response to Chemotherapy and Prognosis in Metastatic Colorectal Cancer With DNA Deficient Mismatch Repair.
Alex AK; Siqueira S; Coudry R; Santos J; Alves M; Hoff PM; Riechelmann RP
Clin Colorectal Cancer; 2017 Sep; 16(3):228-239. PubMed ID: 28063788
[TBL] [Abstract][Full Text] [Related]
14. Development of novel models for predicting mismatch repair protein deficiency and relevant disease-free survival in colorectal cancer patients.
Xu Y; Li Y; Zhu Z; Yang J; Tan Y; Wang Y; Xu X
Int J Colorectal Dis; 2022 Jun; 37(6):1449-1464. PubMed ID: 35482069
[TBL] [Abstract][Full Text] [Related]
15. Deficient DNA mismatch repair is associated with favorable prognosis in Thai patients with sporadic colorectal cancer.
Korphaisarn K; Pongpaibul A; Limwongse C; Roothumnong E; Klaisuban W; Nimmannit A; Jinawath A; Akewanlop C
World J Gastroenterol; 2015 Jan; 21(3):926-34. PubMed ID: 25624727
[TBL] [Abstract][Full Text] [Related]
16. A Radiomics Nomogram Integrated With Clinic-Radiological Features for Preoperative Prediction of DNA Mismatch Repair Deficiency in Gastric Adenocarcinoma.
Tong Y; Li J; Chen J; Hu C; Xu Z; Duan S; Wang X; Yu R; Cheng X
Front Oncol; 2022; 12():865548. PubMed ID: 35912185
[TBL] [Abstract][Full Text] [Related]
17. [Difference analysis of somatic mutations between deficient mismatch repair and proficient mismatch repair gene related with colorectal cancer].
Tang XJ; Yang MY; Zhu LZ; Xu D; Yuan Y
Zhonghua Zhong Liu Za Zhi; 2021 Oct; 43(10):1088-1093. PubMed ID: 34695900
[No Abstract] [Full Text] [Related]
18. Real-world outcome of universal screening for Lynch syndrome in Japanese patients with colorectal cancer highlights the importance of targeting patients with young-onset disease.
Yamada A; Matsuoka Y; Minamiguchi S; Yamamoto Y; Kondo T; Sunami T; Horimatsu T; Kawada K; Seno H; Torishima M; Murakami H; Yamada T; Kosugi S; Sugano K; Muto M
Mol Clin Oncol; 2021 Dec; 15(6):247. PubMed ID: 34712484
[TBL] [Abstract][Full Text] [Related]
19. A review of the sensitivity of metastatic colorectal cancer patients with deficient mismatch repair to standard-of-care chemotherapy and monoclonal antibodies, with recommendations for future research.
Wensink E; Bond M; Kucukkose E; May A; Vink G; Koopman M; Kranenburg O; Roodhart J
Cancer Treat Rev; 2021 Apr; 95():102174. PubMed ID: 33721596
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
